A detailed history of Principal Securities, Inc. transactions in Cure Vac N.V. stock. As of the latest transaction made, Principal Securities, Inc. holds 291 shares of CVAC stock, worth $832. This represents 0.0% of its overall portfolio holdings.

Number of Shares
291
Previous 177 64.41%
Holding current value
$832
Previous $602,000 42.19%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$2.74 - $3.79 $312 - $432
114 Added 64.41%
291 $856,000
Q2 2024

Jul 31, 2024

SELL
$2.31 - $4.99 $129 - $279
-56 Reduced 24.03%
177 $602,000
Q1 2024

May 10, 2024

SELL
$2.94 - $4.34 $20 - $30
-7 Reduced 2.92%
233 $706,000
Q4 2023

Feb 07, 2024

BUY
$3.96 - $6.41 $950 - $1,538
240 New
240 $1.01 Million

Others Institutions Holding CVAC

About CureVac N.V.


  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $536M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.